Display Settings:

Format

Send to:

Choose Destination
See comment in PubMed Commons below
J Diabetes Sci Technol. 2011 May 1;5(3):804-26.

Innovations in technology for the treatment of diabetes: clinical development of the artificial pancreas (an autonomous system).

Author information

  • 1Mills-Peninsula Health Services, San Mateo, California, USA. dklonoff@yahoo.com

Abstract

The Food and Drug Administration in collaboration with the National Institutes of Health presented a public workshop to facilitate medical device innovation in the development of the artificial pancreas (or autonomous system) for the treatment of diabetes mellitus on November 10, 2010 in Gaithersburg, Maryland. The purpose of the workshop was to discuss four aspects of artificial pancreas research and development, including: (1) the current state of device systems for autonomous systems for the treatment of diabetes mellitus; (2) challenges in developing this expert device system using existing technology; (3) clinical expectations for these systems; and (4) development plans for the transition of this device system toward an outpatient setting. The patients discussed how clinical science, system components, and regulatory policies will all need to harmonize in order to achieve the goal of seeing an AP product brought forward to the marketplace for patients to use.

© 2011 Diabetes Technology Society.

PMID:
21722597
[PubMed - indexed for MEDLINE]
PMCID:
PMC3192648
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for HighWire Icon for PubMed Central
    Loading ...
    Write to the Help Desk